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ABSTRACT
Background: Folic acid (FA) fortiﬁcation of food created the need
to determine whether fortiﬁcation elevated concentrations of unme-
tabolized FA in plasma and whether this form of the vitamin in
blood is associated with adverse health outcomes.
Objective: The objective of this research was to devise a simple,
rapid method for the measurement of unmetabolized plasma FA in
epidemiologic studies.
Design: We previously used the afﬁnity/HPLC with electrochemical
detection method to measure folate distribution in human plasma and
red blood cells (RBCs). We modiﬁed this method with the inclusion
of synthetic ethyltetrahydrofolate as an internal standard and with the
use of 2 afﬁnity columns connected in parallel to the analytic column
through a switching valve to allow one column to be loaded while the
other column was eluted into the analytic column.
Results: We identiﬁed FA and 5-methyltetrahydrofolate (5-mTHF)
by retention time and characteristic response across the channels of
the electrochemical detector. Limits of detection were 0.034 pmol
for 5-mTHF and 0.027 pmol for FA per injection, and the recovery
was 92.2% (5-mTHF) and 98.9% (FA). CVs for samples were 8.1%
for (within day) and 6.8% (between day) for 5-mTHF and 3.2%
(within day) and 5.9% (between day) for FA. Total folate with the
use of this method correlated highly (r
2 = 0.98, P , 0.001) with
values from the microbial assay. The run time for the method was
30 min per sample. Researchers can use this method with longer run
times to measure the distribution of folate forms in RBCs.
Conclusion: This updated method allows efﬁcient analysis of folate
forms in human plasma and tissues without the loss of sensitivity or
precision. Am J Clin Nutr doi: 10.3945/ajcn.111.013433.
INTRODUCTION
To decrease the incidence of neural tube defects, the US Food
and Drug Administration mandated fortiﬁcation of all enriched
cereal-grain products with folic acid (FA) by January 1998 (1).
This policy was associated with a decrease in neural tube defects
(2) and stroke-related mortality in the United States (3). In ad-
dition, fortiﬁcation was associated with the virtual elimination of
folate deﬁciency and a decrease in plasma homocysteine con-
centrations (4–7).
FA, the form offolate that manufacturers use for fortiﬁcation, is
a synthetic form of the vitamin that requires reduction to tetra-
hydrofolate (THF) before incorporation into the active cellular
folate pool. In humans, this reduction has limited capacity, and
when people take excess FA (ie, .200 lg), elevated amounts of
unmodiﬁed FA appear in the circulation (8, 9). Eventually, the
body converts much of this FA into THF and the peripheral tissue
takes up the THF and incorporates it into cellular folate.
A recent study from our group has shown that in women ag-
ed .60 y, plasma FA concentrations have an inverse relation to
natural killer cell cytotoxicity (10). This ﬁnding is consistent
with recent suggestions that high concentrations of unmetabo-
lized FA in the circulation are potentially harmful (11, 12).
However, because of the lack of suitable methods to measure
unmetabolized FA in populations, research in this area has been
limited. We describe a modiﬁcation of our method that com-
bines afﬁnity/HPLC with electrochemical detection for folate
analysis (13) to measure unmetabolized FA concentrations in
plasma for population studies.
MATERIALS AND METHODS
Preparation of samples
We selected plasma samples for the assays from the archived
plasma pools we used in our laboratory. We thawed these samples at
least once for various measurements but otherwise kept them
at 280C. We mixed the plasma samples (0.2 mL) in a cold ice
bath with 1.2 mL of 50 mmol potassium tetraborate/L that con-
tained 1% sodium ascorbate (pH 9.0). We added 20 pmol of syn-
thetic ethyltetrahydrofolate (eTHF) to each plasma sample as an
internal standard. We vortexed the mixture and boiled it for 30 min.
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HPLC analysis, we ﬁltered the samples with a 0.22-lm ﬁlter and
used the ﬁltrate for analysis or kept it at 280C until the analysis.
We extracted folate from red blood cells (RBCs) with the use of
a method similar to the one we described for plasma, except that
we added Triton X-100 (0.2%) to the extraction buffer.
Afﬁnity/HPLC
The afﬁnity/HPLC system consisted of 1) 2 afﬁnity columns that
we connected in parallel through a Rheodyne 7126 automatic,
10-port/2-position switching valve (Rohnert Park, CA) to an analytic
column (Betasil Phenyl 250 · 4.6 mm; Keystone Scientiﬁc, Belle-
fonte, PA); 2) a Waters model 515 pump (Milford, MA); 3)a n
Agilent 1100 HPLC system (Santa Clara, CA) with ChemStation
software and a quaternary pump with vacuum degasser and cooled
liquid sampler with an automatic injector; and 4) an ESA Coul-
Array electrochemical detector (Chelmsford, MA) with a Model
6210 4-sensor cell. We controlled all of the operations except the
Waters pump with the use of the Agilent 1100 software.
An outline of the system is provided in Figure 1.P u m pA
(Waters), which connected to the Agilent injection valve, de-
livered mobile phase C (0.05 mmol potassium phosphate/L, pH
7.0, which contained 5% acetonitrile) at a constant rate of 0.35
mL/min. The purposes of this step were equilibration; sample
loading into the afﬁnity columns; and subsequent washing to rid
the column of nonfolate material, particularly the ascorbate that
we used for sample preparation, which interferes with the elec-
trochemical detection. Pump B (Agilent) delivered an acetonitrile
gradient at acid pH through the second afﬁnity column and the
analytic column. The purpose of this process was to elute the
folate from the afﬁnity column and subsequent fractionation by
the analytic column for electrochemical detection.
The gradient comprised mobile phase A, whose buffer was
28 mmol dibasic potassium phosphate/L and 60 mmol phosphoric
acid/L(pH3.0),andmobilephaseB,whichusedthesamebufferas
mobile phase A with 20% acetonitrile. The elution schedule is
presented in Table 1. We set the cell potentials for the electro-
chemical detector at 0, 300, 500, and 600 mV for channels 1–4.
We automatically set the detector at zero 0.25 min into the run.
We performed the cell cleaning function at 700 mV per cell for
30 s at the end of each sample. Except for the Waters pump, we
controlled the Rheodyne switching valve and the ESA on and
off positions through contact switches in the ChemStation
software.
The system delivered the injected sample (900 lL) into afﬁnity
c o l u m n1( F i g u r e1 )a n ds u b s e q u e n t l yw a s h e di tw i t hm o b i l e
phase C until a signal from the ChemStation caused the Rheodyne
valve to switch to position 2. While the system loaded afﬁnity
column 1 with the sample, it eluted the folate in afﬁnity column 2
into the analytic column and then performed fractionation and
electrochemical analysis. The Rheodyne valve was switched to
position 2 to reverse the procedures for the 2 afﬁnity columns.
Run time and injection time totaled 30 min per sample.
We applied the same principle of 2 afﬁnity columns and elec-
trochemical detection for analysis of RBC folate, which comprises
folate forms that have different levels of polyglutamation. In this
case, the run time was longer (50 min) to allow for the elution and
separation of these polyglutmatyl folates (Table 2).
Preparation of folate standards
We synthesized eTHF from THFas follows: we added 1 mg THF
(Sigma-Aldrich, St Louis, MO) to a tube that contained 0.05mL
acetaldehyde and 0.02 mL mercaptoethanol. We kept this solution
on ice and then added 25 mg solid potassium borohydride. We
cappedthetubewitharubberstopperandinsertedasyringeneedle.
We incubated this solution at 37Cf o r1ha n dt h e nc o o l e da n d
neutralized it with glacial acetic acid. We purchased other folate
standards of 5-methyltetrahydrofolate (5-mTHF) and FA from
Sigma-Aldrich.
We puriﬁed all of the folate standards on a diethylaminoethyl
cellulose column. We measured the purity and concentration of
each standard separately with the use of a spectrophotometer
(PerkinElmer LAMBDA 7 ultraviolet/Vis; Waltham, MA). We used
the quantiﬁed standards to make external standards of 1 nmol/mL in
1% sodium ascorbate. We made fresh standards every month and
stored them at 280C in evacuated tubes.
We identiﬁed the folate forms by comparison of retention times
andcharacteristicresponseacrosschannelswiththoseoftheexternal
standards. We ran the external standard mixtures that contained 20
pmoleachof5-mTHF,eTHF,andFApermLatthestartandendof
each batch. To quantify 5-mTHF and FA in plasma, we added 20
pmolofeTHFtothesampleandextractionbufferbeforeextraction.
Wecalculatedthesumoftheintegratedareasofallpeaksinchannels
thatshowed aresponse(in lA)for 5-mTHFand FA,multipliedthe
total by 20 pmol (the number of pmol of eTHF), and divided the
result by the total area of all integrated peaks (in lA) for eTHF.
FIGURE 1. Flow diagram for the 2 online afﬁnity columns connected
through a 10-port, 2-position valve to an analytic column and a CoulArray
detector (ESA, Chelmsford, MA) to evaluate folate forms. When the valve
switch is in position 1, afﬁnity column 1 is loaded with the sample and washed
while afﬁnity column 2 is eluted into the analytic column. These processes are
reversed when valve switch is in position 2.
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Weinjectedstandardsthatcontained0.5–200pmolperinjection
for 5-mTHF, eTHF, and FA in triplicate to show the linearity of
signals. We calculated limits of detection for 5-mTHF and FA by
serial dilution of a plasma sample with water (10–100 times) and
quantiﬁcation of each sample.
Recovery of standards
To measure the recovery of added folate standards to plasma,
we extracted 10 aliquots of the same plasma sample. We ran 5 of
the plasma extracts alone and added 20pmol of 5-mTHF, FA, and
eTHF to the other 5 plasma extracts before extraction. We also
ran 5 standards of 20 pmol each of 5-mTHF, FA, and eTHF. We
calculated the amount offolate from the spiked plasma minus the
amount of folate and divided the results by the amount of folate
from the standard alone to measure recovery.
Precision
We measured CVs for intra- and interassay precision for
5-mTHF and FA with the use of eTHF as an internal standard in
plasma.Weextractedaplasmasampleandranitintriplicateonthe
same day for intraassay precision. For interassay precision, we ran
the plasma sample in triplicate on 3 separate days over 2 wk.
Microbial assay for folate
We measured total folate of the plasma samples by microbial
assay with the use of Lactobacillus casei, as we have described
previously (14, 15). Brieﬂy, we serially diluted 5 lL of each
plasma sample and plated the samples in triplicate onto a
96-microtiter well plate with 150 lLo fL. casei growth medium.
We incubated the plates overnight in a 37C humid incubator and
measured the absorbance, which indicated microbial growth, with
the use of a 96-well plate reader (PowerWave HT; BioTek In-
struments Inc, Winooski, VT) at 595 nm.
RESULTS
Chromatograms of folate forms
Examples of chromatograms for the external standards are
shown in Figure 2A and a plasma sample with eTHF as the
internal standard is shown in Figure 2B. The forms of folate we
observed in plasma were 5-mTHF and FA. We also extracted
folates from RBC samples and separated the polyglutamyl forms
of methylfolate (Figure 2C).
Folate form distributions in plasma samples
We extracted folates from 168 archival fasted plasma samples.
The median of 5-mTHF with the use of the HPLC method was
39.64 (range: 3.82–218.2) pmol/L. For unmetabolized FA con-
centrations, the median was 0.63 (range: 0–2.54) pmol/L. On
average, unmetabolized FA accounted for 1.57% of total folate,
with a range of 0–11.71%. We could detect unmetabolized FA in
43.4% of the samples. We detected no other forms of folate in
these samples.
TABLE 1
Operating sequence for the chromatographic system to analyze plasma folate
1
Time Afﬁnity column 1 (switching valve: position 1) Time Afﬁnity column 2 (switching valve: position 1)
min
24 to 0 min Pump A: 0.5 mL/min for afﬁnity column equilibration;
sample loading into 900-lL loop
24 to 3 Pump B: 1 mL/min of 70% A and 30% B for elution of folate
into the analytic column, preparation for folate fractionation
>0 to 2 min Injection signal and sample loading into the afﬁnity column 0 Signal to start ESA recording, begin folate fractionation
>2 to 25 min Washing of afﬁnity column >3 to 13 Pump B: 1 mL/min, 10% A and 90% B
>25 min End of column wash and signal to valve to switch to
position 2
>13 to 17 Pump B: 1 mL/min, 0% A and 100% B
>17 to 25 Pump B: 1 mL/min 70% A and 30% B
>25 End of folate analysis and signal to switch valve to position 2
1 Pump A is the Waters pump (Milford, MA), which pumps 0.05 mmol/L potassium phosphate (pH 7) with 5% acetonitrile. Pump B is the Agilent pump
(Santa Clara, CA), which pumps mobile phase A [28 mmol dibasic potassium phosphate/L and 60 mmol phosphoric acid/L (pH 3.0)] and B (the same as A
with the addition of 20% acetonitrile). ESA, ESA CoulArray electrochemical detector (Chelmsford, MA).
TABLE 2
Operating sequence for chromatography with the use of 2 afﬁnity columns to analyze folate in red blood cells
1
Time Afﬁnity column 1 (switching valve: position 1) Time Afﬁnity column 2 (switching valve: position 1)
min
24 to 0 min Pump A: 0.35 mL/min for afﬁnity column equilibration,
sample loading into 900-lL loop
24 to 3 Pump B: 1 mL/min of 90% A and 10% B for elution of folate
into the analytic column, preparation for folate fractionation
>0 to 2 min Injection signal and sample loading into the afﬁnity column 0 Signal to start ESA recording, begin folate fractionation
>2 to 50 min Washing of afﬁnity column 0 to 5 Pump B: 1 mL/min, 90% A and 10% B
50.01 min End of column wash and signal to valve to switch to
position 2
>5 to 15 Pump B: 1 mL/min, 70% A and 30% B
>15 to 40 Pump B: 1 mL/min 45% A and 55% B
>40 to 50 Pump B: 1 mL/min 35% A and 65% B
50.01 End of folate analysis and signal to valve to switch to position 2
1 Pump A is the Waters pump (Milford, MA), which pumps 0.05 mmol/L potassium phosphate (pH 7) with 5% acetonitrile. Pump B is the Agilent pump
(Santa Clara, CA), which pumps mobile phase A [28 mmol dibasic potassium phosphate/L and 60 mmol phosphoric acid/L (pH 3.0)] and B (same as Awith
the addition of 20% acetonitrile). ESA, ESA CoulArray electrochemical detector (Chelmsford, MA).
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We showed a linear relation between the peak area and the
concentration of each folate form over the ranges we tested (r
2 =
0.997–0.998). When we used a signal-to-noise ratio of 3, the limit
of detection was 0.034 pmol for 5-mTHF and 0.027 pmol for
FA per injection. These values corresponded to 0.26 pmol/mL
plasma for 5-mTHF and 0.21 pmol/mL for FA. In a few samples,
we detected FA even at concentrations below the calculated limit
of detection. The recovery rate (mean 6 SE) for samples spiked
with standards was 92.2 6 2.1% for 5-mTHF, 98.9 6 5.2% for
FA, and 93.8 6 4.0% for eTHF. CVs for samples were 8.1%
(within day) and 6.8% (between day) for 5-mTHF and 3.2%
(within day) and 5.9% (between day) for FA (Table 3).
Comparison of HPLC and microbial assays for folate
measurement
The correlation between the HPLC and L. casei methods was
0.979 (P , 0.001). On average, the HPLC yielded total folate
values that were 1.09-fold higher (mean 1.09 6 0.23 SD) than
the L. casei method. The HPLC method typically produces
values that are higher than those of the L. casei method (13, 16).
The lower activity level we observed in the L. casei assay was
probably a consequence of a small loss of folate in the micro-
biological assay during the required 24-h incubation period. The
mean difference between the HPLC and L. casei assay results
was 1.65 pmol/mL, which was not signiﬁcant (95% CI for the
mean difference: 20.053, 0.004).
DISCUSSION
In its original design, the afﬁnity/HPLC system for assessment of
folate form distribution is based on the use of puriﬁed and im-
mobilized high-afﬁnity folate binding protein on a matrix to con-
centrate and purify folate from biological samples. The next steps
are elution and fractionation of retained folates by reverse-phase
columnchromatographyandmeasurementoffolateactivitywiththe
use of multichannel ultraviolet absorption that a diode array system
facilitates. A single chromatography provides information on both
thepteridinering/one-carbonsubstitutionstructuresandtheextentof
polyglutamation of individual folates (17).
We have used this method previously to assess folate form
distribution in a number of animal tissues for different experimental
models, and in a number of food products (18–20). Nevertheless,
the original method has some disadvantages. The method uses
sepharose as the matrix for the immobilized folate binding protein
(21), which requires manual injection of the sample into the HPLC
system. Another disadvantage is that ultraviolet detection is rela-
tively insensitive and the system therefore requires a considerable
amount of the biological specimen to allow detection of all activity
peaks.
The modiﬁed afﬁnity/HPLC with electrochemical detection
method, which we also devised (13), used a polymer-based matrix
for folate binding proteinimmobilization, which thusallowed online
placementoftheafﬁnitycolumnforautomaticsampleinjection.The
FIGURE 2. Chromatograms of external standards (A), human plasma
sample (B), and red blood cells (C). The panels show the electrochemical
response of channels 1, 2, 3, and 4 at 0, 300, 500, and 600 mV, respectively.
A: Chromatogram for 20 pmol each of standards 5-methyltetrahydrofolate (M),
ethyltetrahydrofolate (E), and folic acid (F). B: Chromatogram of a plasma sample
that contained 5-methyltetrahydrofolate (M), ethyltetrahydrofolate (E), and folic
acid (F). C: Chromatogram of red blood cell folate analysis. The peaks represent
5-methyltetrahydrofolate (m) with 4, 5, 6, 7, 8, and 9 glutamic acid residues.
TABLE 3
Performance statistics for the afﬁnity HPLC method
1
Intraassay (n = 3) Interassay (n =9 )
Folate form Mean CV Mean CV
ng/mL % ng/mL %
5-mTHF 16.9 8.1 16.2 6.8
Folic acid 31.5 3.2 32.1 5.9
1 To convert folate values to nanomoles per liter, multiply the amount
by 2.266. CV was calculated with the use of Microsoft Excel software
(Seattle, WA). 5-mTHF, 5-methyltetrahydrofolate.
4S of 5S KALMBACH ET AL2-position 6-port Rheodyne valve between the afﬁnity column and
the analytic column allowed separation of the 2 columns during
loading and subsequent washing of the afﬁnity column. The use of
a 4-channel electrochemical detector from ESA set at different
voltages allowed identiﬁcation of the different folate forms at a 10–
20-fold higher sensitivity than with ultraviolet detection. Mod-
iﬁcations also included a different analytic column (Betasil C18;
Keystone), which served as an immobilized ion pair, and a different
mobile phase. The ion pairing mobile phase system that the old
method used is not feasible with electrochemical detection.
We have used this afﬁnity/HPLC with electrochemical de-
tection method to show the presence of nonmethylated THF
polyglutamates in RBC fromhomozygotes forthe 677Tmutation
in the MTHFR gene (22). We have also used the method to show
the high concentrations of unmetabolized FA and 5-mTHF in
patients undergoing kidney dialysis who were receiving high
doses of FA (23). Finally, we have used the method in a study
that showed an inverse correlation between unmetabolized FA
(but not 5-mTHF) in plasma and natural killer cell activity (10).
Evenwiththesystem’smanyimprovements,analysisofasingle
sample took 75 min, which makes this method impractical for
epidemiologic analyses. In this article, we describe how we mo-
diﬁed this method to measure unmetabolized FA in plasma for
epidemiologic studies. Instead of one afﬁnity column, we used 2
columns that we linked to a 2-position, 10-port switching valve.
This approach facilitated the ability toloadand subsequently wash
one column while the other column was eluted into the analytic
column for folate fractionation and subsequent electrochemical
analysis (Table 1). Except for the ﬁrst cycle, which took 60 min to
generatetheﬁrstsetof data,subsequentcyclesprovideddataevery
30 min, and we could run ’45–47 samples every 24 h.
Another improvement is the use of synthetic eTHF as an internal
standard to account for any loss of folate during extraction and
subsequentbindingtotheafﬁnitycolumn.TheusefulnessofeTHFas
an internal standard is evident from the low intra- and interassay CVs
and high correlations between the total folate (ie, FA plus 5-mTHF)
that we had determined by this method and the L. casei assay.
In summary, this method is suitable for population studies
because of its high throughput, requirement for only a small
amountofplasma,anduseofaninternalstandard.Researcherscan
also use this method to analyze folate form distribution in cells.
Further research is needed to determine whether measurement of
unmetabolized FA in plasma samples would provide additional
information to recent suggestions that fortiﬁcation with FA has an
association with adverse health outcomes (10–12).
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